SWTX - SpringWorks Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2025-02-11    (Delayed quote data   2025-01-06)
Last
 38.86		 Change
 ⇑ +0.67   (+1.75%)		 Volume
  1,267,354
Open
 38.21		 High
 40.03		 Low
 37.77
8EMA (Daily)
 37.34		 40EMA (Daily)
 37.13		 50EMA (Daily)
 36.90		 STO (Daily)
 47.659		 MACD Hist (Daily)
 0.076
8EMA (Weekly)
 37.607		 40EMA (Weekly)
 37.14		 50EMA (Weekly)
 37.02		 STO (Weekly)
 55.344		 MACD Hist (Weekly)
 0.853
Company Profile
SpringWorks Therapeutics Inc is a United States-based biopharmaceutical company. It is focused on identifying, developing, and commercializing therapies for underserved patient populations suffering from severe rare diseases and cancer. The firm's pipeline product includes Mirdametinib, Nirogacestat, and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com